Thu.Aug 25, 2022

article thumbnail

Leukemia Patients Turn to Online Pharmacies Due to Escape High Drug Prices

Drug Topics

Researchers report that half of the online pharmacies are rogue operations that may operate without a license or have other serious shortcomings.

187
187
article thumbnail

Pharmacists and Deprescribing in a Palliative Care Setting

Pharmacy Times

As pharmacists take on new responsibilities, researchers have been studying the effects of pharmacists on interprofessional care teams.

158
158
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

COVID-19: An Attack on the Brain

Drug Topics

What are the long term psychiatric and neuropsychiatric complications of COVID-19?

187
187
article thumbnail

Blister material as a source of nitrosamine impurities

European Pharmaceutical Review

Following numerous recalls, the industry is striving to investigate the causes, sources and ways to mitigate carcinogenic nitrosamine impurities. In a recent paper, published in the International Journal of Pharmaceutics , researchers identified nitrocellulose blister packaging as a potential source of N -nitrosodimethylamine (NDMA) and N -nitrosodiethylamine (NDEA) impurities.

Packaging 142
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Making coupons count for patients at the pharmacy counter

PhRMA

Too many patients face high out-of-pocket costs for brand medicines, even when they have insurance.

Insurance 147
article thumbnail

COVID-19 Vaccine Booster Dose Reduces Infection, Hospitalization, Death from Virus in Long-Term Care Facilities

Pharmacy Times

During the surge caused by the Delta variant, a third dose of the Pfizer-BioNTech COVID-19 vaccine reduced infections and COVID-19-related hospitalizations and deaths among patients in long term care facilities.

More Trending

article thumbnail

Pfizer, BioNTech Announce Updated COVID-19 Vaccine Efficacy Data for Young Children

Pharmacy Times

Analysis is based on previously reported data collected in March and April 2022, with the FDA granting emergency use authorization for individuals aged 6 months to 4 years on June 17.

Vaccines 122
article thumbnail

EC grants approval for BioMarin’s gene therapy to treat Hemophilia A

Pharmaceutical Technology

The European Commission (EC) has granted conditional marketing authorisation (CMA) for BioMarin Pharmaceutical ’s gene therapy, Roctavian (valoctocogene roxaparvovec), to treat adults with severe haemophilia A (congenital Factor VIII deficiency). The treatment is indicated for patients with no history of Factor VIII inhibitors and any detectable antibodies to adeno-associated virus serotype 5 (AAV5).

105
105
article thumbnail

FDA Approves Ibrutinib for Pediatric Patients With Chronic Graft-Versus-Host Disease

Pharmacy Times

Ibrutinib (Imbruvica) is the first therapy to gain FDA approval for younger patients who had no prior treatment options for chronic graft-versus-host disease.

FDA 123
article thumbnail

COVID-19 Incubation Period Varies by SARS-CoV-2 Strain

Drug Topics

With the evolution of different COVID-19 variants, finding the mean incubation period has become more complex.

112
112
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Coping With Burnout and Stress in Community Pharmacies

Pharmacy Times

The panel of experts share personal experiences with burnout in the pharmacy setting and outline opportunities for improving the atmosphere of the workplace.

article thumbnail

Pharmacy Profit Summit Speaker Highlights 2022 – Day 2

DiversifyRx

If you missed the Day 1 Pharmacy Profit Summit recap, you can catch it here. Day 2 was packed with even more speakers that gave critical information on how to grow your profits with various solutions. Let’s dive into day two and get the specific information you need. Dr. Lisa Faast. Dr. Faast started by welcoming everyone back and sharing information about projects and offers for attendees.

article thumbnail

Opioid Tapering: Pharmacists Can Make a Difference

Pharmacy Times

Pharmacists, being one of the most accessible health care professionals, are critical pieces of the opioid tapering program puzzle.

123
123
article thumbnail

Fatty liver disease: With little early detection, more challenging drug development

pharmaphorum

For most of my adult life, I had been the typical American fat guy, gaining a pound or two a year and thinking little of it. That was until my doctors stunned me with the news that I had cirrhosis caused by non-alcoholic steatohepatitis, or NASH, a severe form of fatty liver disease that often has few or no symptoms until very late stages. I had never heard of NASH, and I was even more shocked when I started searching online and discovered the prevalence of the disease and the tragic reality tha

FDA 98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Managing Increasingly Demanding Workflows for Pharmacists and Technicians

Pharmacy Times

Expanding technician roles may lead to improved efficacy in the workplace and alleviate burdens overwhelming pharmacists.

123
123
article thumbnail

J&J gets first approval for multiple myeloma bispecific Tecvayli

pharmaphorum

Johnson & Johnson has its first worldwide regulatory approval – in the EU – for Tecvayli, one of two much-anticipated bispecific antibodies the drugmaker has developed for patients with multiple myeloma. The double-headed antibody binds to CD3 on T cells and redirects them to BCMA-expressing myeloma cells, with the aim of stimulating an immune attack on the tumour, which remains incurable despite a slew of new therapies reaching the market in recent years.

FDA 98
article thumbnail

Foot Care Is Essential for Patients With Diabetes

Pharmacy Times

With proper knowledge, they can complete self-examinations and be adherent to clinical exams.

139
139
article thumbnail

Aetna Medicaid donates $450K to support Texas communities

Drug Store News

The donations support the work of healthcare providers and amplify the impact community organizations have on meeting the needs of families with individuals who have intellectual or developmental disabilities.

97
article thumbnail

Pfizer Announces Positive Findings in Phase 3 Trial of Bivalent Respiratory Syncytial Virus Vaccine Candidate in Older Adults

Pharmacy Times

The vaccine candidate is composed of 2 preF proteins selected to optimize protection against the RSV A and B strains.

Vaccines 123
article thumbnail

Walmart, myQ bring grocery delivery to garages

Drug Store News

With the Walmart+ InHome delivery service, customers will be able to purchase essentials from the Walmart app and have the option of having them delivered to the garage.

98
article thumbnail

Plaque Psoriasis Treatment Gets Even More Company

Drug Topics

Nonsteroidal topical agents and TYK2 inhibitors may join an already full armamentarium.

112
112
article thumbnail

Oncolytic viruses: past and present

European Pharmaceutical Review

IN 2022, treating glioblastoma (GBM) remains an uphill battle. Current therapeutic options show limited success and neuro-oncology teams often struggle to balance their benefits with a patient’s quality of life. Cutting-edge strategies, however, are now revisiting the use of oncolytic viruses – viruses that selectively infect and kill cancer cells – which may broaden and advance the therapeutic landscape.

article thumbnail

Give Your Pharmacy a Facelift | Featuring: Gabe Trahan

PioneerRx

A building sits on the street corner of a downtown suburb. It boasts a sharp exterior, an eye-catching sign, and an atmosphere that beckons you in. Open up the.

97
article thumbnail

Accelerating timelines for development and manufacture of multi-specific antibodies

European Pharmaceutical Review

Novel treatment options for an array of ever more biologically complex disease modalities require therapies that can simultaneously engage multiple targets. Drug developers have responded by creating diverse families of bispecific (bsAb) and multi-specific antibody (msAb) therapies often comprising three or more polypeptide chains. Depending on the specific product, critical quality attributes, formulation requirements and selected programme design, it is now possible for standard monoclonal ant

94
article thumbnail

Senator Burr: Rip Van Winkle Performance on Drug Importation, Owes Italy an Apology 

Policy Prescription

This past June, during a debate in the Senate Health, Education, Labor and Pensions (HELP) Committee, Senator Richard Burr (R-NC), the committee’s Ranking Member, demonstrated that he does not understand very important developments in our nation’s approach to drug regulation and safety. It was almost as if Sen. Burr had fallen asleep over 20 years ago and woke up believing that nothing had changed in the world of drug regulation.

FDA 89
article thumbnail

Efficient water determination accelerates API development

European Pharmaceutical Review

DURING THE development of new types of active pharmaceutical ingredients (APIs) or medicinal products, scale-up at a pilot plant is an important proof of concept. Offering the opportunity to assess the efficacy of a synthesis and refine it prior to production stages, these facilities are both critical and integral to development processes. Various analyses of batches are essential to success, with one of the central quality parameters assessed in pilot plants being water content.

92
article thumbnail

New Treatment Options Are on the Horizon for ?-Thalassemia

Pharmacy Times

Gene therapies in late-stage development may soon provide hope for a cure.

123
123
article thumbnail

Koye Pharma allies with Sonde on vocal biomarkers for COPD

pharmaphorum

Indian drugmaker Koye Pharma has partnered with Sonde Health to develop its vocal biomarker technology – which aims to diagnose diseases from voice patterns – for use in chronic obstructive pulmonary disease (COPD). Mumbai-based Koye is the first pharma company to partner with Sonde Health on the technology, which is also being used in a standalone app to monitor people’s mental health and wellbeing.

article thumbnail

Sandoz to become standalone company

European Pharmaceutical Review

Novartis has announced that it intends to separate Sandoz , its generics and biosimilars division into a new publicly traded standalone company. The 100 percent spin-off aims to establish Sandoz as the premier European generics company and a global leader in biosimilars, maximising shareholder value. For both the Innovative Medicines and Sandoz businesses, the spin-off would enable enhanced focus and the ability to pursue independent growth strategies.

article thumbnail

Study Identifies Cancer, Cardiovascular Disease as Top Drivers of Employer Health Care Costs

Pharmacy Times

In a recent survey, researchers identified rising costs, socioeconomic inequity, and drug trends as major concerns for large employers.

123
123
article thumbnail

Kroger names 2nd annual Go Fresh & Local Supplier Accelerator winners

Drug Store News

Five small local and regional brands were selected to diversify Kroger's product offerings and receive strategic mentorship.

97
article thumbnail

Twice yearly HIV treatment approved in Europe

European Pharmaceutical Review

The European Commission (EC) has granted marketing authorisation to a new, twice yearly treatment option for people whose HIV no longer effectively responds to their current therapy. Gilead’s Sunlenca ® (lenacapavir) injection and tablets was granted authorisation in adults with multi-drug resistant HIV infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

article thumbnail

Amazon adopts green hydrogen to help decarbonize its operations

Drug Store News

Plug Power will supply Amazon with green hydrogen for its transportation and building operations beginning in 2025.

96
article thumbnail

BMS forges multi-year research partnership with PathAI

Outsourcing Pharma

The pharmaceutical company and the artificial intelligence pathology specialist will focus on translational research in oncology, fibrosis, and immunology.